- Home
- BBIO vs FICO Comparison
BBIO vs FICO Comparison
Compare BBIO & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- FICO
- Stock Information
- Founded
- BBIO 2015
- FICO 1956
- Country
- BBIO United States
- FICO United States
- Employees
- BBIO N/A
- FICO N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- FICO Business Services
- Sector
- BBIO Health Care
- FICO Consumer Discretionary
- Exchange
- BBIO Nasdaq
- FICO Nasdaq
- Market Cap
- BBIO 6.7B
- FICO 48.4B
- IPO Year
- BBIO 2019
- FICO 1987
- Fundamental
- Price
- BBIO $34.48
- FICO $2,093.61
- Analyst Decision
- BBIO Strong Buy
- FICO Buy
- Analyst Count
- BBIO 12
- FICO 12
- Target Price
- BBIO $57.09
- FICO $2,236.75
- AVG Volume (30 Days)
- BBIO 3.2M
- FICO 182.1K
- Earning Date
- BBIO 04-29-2025
- FICO 04-29-2025
- Dividend Yield
- BBIO N/A
- FICO N/A
- EPS Growth
- BBIO N/A
- FICO 21.78
- EPS
- BBIO N/A
- FICO 23.21
- Revenue
- BBIO $127,415,000.00
- FICO $1,840,361,000.00
- Revenue This Year
- BBIO $13.67
- FICO $17.79
- Revenue Next Year
- BBIO $118.02
- FICO $15.57
- P/E Ratio
- BBIO N/A
- FICO $90.72
- Revenue Growth
- BBIO N/A
- FICO 14.71
- 52 Week Low
- BBIO $21.62
- FICO $1,240.31
- 52 Week High
- BBIO $39.47
- FICO $2,402.52
- Technical
- Relative Strength Index (RSI)
- BBIO 49.67
- FICO 68.95
- Support Level
- BBIO $33.92
- FICO $2,035.94
- Resistance Level
- BBIO $39.16
- FICO $2,112.05
- Average True Range (ATR)
- BBIO 1.43
- FICO 53.87
- MACD
- BBIO -0.16
- FICO 15.94
- Stochastic Oscillator
- BBIO 31.05
- FICO 94.48
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.